NYSE ARCA | ETF
The index tracks the performance ofU. S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients.
The fund invests at least 80% of its total assets in the component securities of the index.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 9.46% |
| DGX | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | 5.96% |
| LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 5.54% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 5.09% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 4.72% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 4.56% |
| BIO | Bio-Rad Laboratories Inc | Healthcare | Medical Devices | 4.49% |
| ZLAB | Zai Lab Ltd | Healthcare | Biotechnology | 3.94% |
| QDEL | Quidel Corporation | Healthcare | Medical Devices | 3.87% |
| IMCR | Immunocore Holdings Ltd | Healthcare | Biotechnology | 3.71% |
| QL1A | QUIDELORTHO DL-001 | Healthcare | Medical Devices | 3.64% |
| NK | NantKwest Inc | Healthcare | Biotechnology | 3.55% |
| BCRX | BioCryst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.46% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.37% |
| NVAX | Novavax Inc | Healthcare | Biotechnology | 3.35% |
| VIR | Vir Biotechnology Inc | Healthcare | Biotechnology | 3.18% |
| ABCL | Abcellera Biologics Inc | Healthcare | Biotechnology | 2.99% |
| OPK | Opko Health Inc | Healthcare | Diagnostics & Research | 2.22% |
| CVAC | CureVac NV | Healthcare | Biotechnology | 1.83% |
| EBS | Emergent Biosolutions Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.72% |